Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Matthew G McDonald"'
Autor:
Judit Marsillach, Stephanie M Suzuki, Rebecca J Richter, Matthew G McDonald, Peter M Rademacher, Michael J MacCoss, Edward J Hsieh, Allan E Rettie, Clement E Furlong
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e110054 (2014)
Homocysteinylation of lysine residues by homocysteine thiolactone (HCTL), a reactive homocysteine metabolite, results in protein aggregation and malfunction, and is a well-known risk factor for cardiovascular, autoimmune and neurological diseases. Hu
Externí odkaz:
https://doaj.org/article/1fb2e390fbb54bd099f64d51bb0122ba
Autor:
Ram Naresh Pandey, Tim Sen Wang, Emmanuel Tadjuidje, Matthew G McDonald, Allan E Rettie, Rashmi S Hegde
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e84582 (2013)
The tyrosine phosphatase activity of the phosphatase-transactivator protein Eyes Absent (EYA) is angiogenic through its roles in endothelial cell migration and tube formation. Benzbromarone, a known anti-gout agent, was previously identified as an in
Externí odkaz:
https://doaj.org/article/7a4d07bcf68a464ca9dff25cd832a408
Autor:
Matthew G. McDonald, Catherine K. Yeung, Aaron M. Teitelbaum, Amanda L. Johnson, Shinya Fujii, Hiroyuki Kagechika, Allan E. Rettie
Publikováno v:
Journal of Lipid Research, Vol 60, Iss 4, Pp 892-899 (2019)
Vitamin K (VK), in both its phylloquinone and menaquinone forms, has been hypothesized to undergo ω- and β-oxidation on its hydrophobic side chain in order to generate the observed urinary metabolites, K acid I and K acid II, which are excreted pri
Externí odkaz:
https://doaj.org/article/f76ce9485fad4bcdba19644badf8ed00
Autor:
Katherine A. Sitko, Lai Hong Wong, Allan E. Rettie, Gabriel Boyle, Clara J. Amorosi, John P. Kowalski, Melissa A Chiasson, Douglas M. Fowler, Maitreya J. Dunham, Matthew G. McDonald
Publikováno v:
Am J Hum Genet
CYP2C9 encodes a cytochrome P450 enzyme responsible for metabolizing up to 15% of small molecule drugs, and CYP2C9 variants can alter the safety and efficacy of these therapeutics. In particular, the anti-coagulant warfarin is prescribed to over 15 m
Publikováno v:
Drug Metab Dispos
Botanical and other natural products (NPs) are often coconsumed with prescription medications, presenting a risk for cytochrome P450 (P450)-mediated NP-drug interactions. The NP goldenseal (Hydrastis canadensis) has exhibited antimicrobial activities
Autor:
Michele Scian, Dale Whittington, Matthew G. McDonald, Constanze Wiek, Miklos Guttman, Allan E. Rettie, John P. Kowalski, Marco Girhard, Helmut Hanenberg
Publikováno v:
Chemical Research in Toxicology. 32:2488-2498
Cytochrome P450 4B1 (CYP4B1) has been explored as a candidate enzyme in suicide gene systems for its ability to bioactivate the natural product 4-ipomeanol (IPO) to a reactive species that causes cytotoxicity. However, metabolic limitations of IPO ne
Autor:
Seung-been Lee, Deborah A. Nickerson, Kenneth E. Thummel, Erin G. Schuetz, Allan E. Rettie, Maitreya J. Dunham, Andrea Gaedigk, Rachel Dalton, Bhagwat Prasad, Brian Phillips, Timothy A. Thornton, Erica L. Woodahl, Mitch Fade, Lai Hong Wong, Douglas M. Fowler, Matthew G. McDonald, Danny D. Shen, Katrina G. Claw
Publikováno v:
Clinical and Translational Science. 13:147-156
The cytochrome P450 2D6 (CYP2D6) gene locus is challenging to accurately genotype due to numerous single nucleotide variants and complex structural variation. Our goal was to determine whether the CYP2D6 genotype-phenotype correlation is improved whe
Autor:
Aaron M. Teitelbaum, Catherine K. Yeung, Matthew G. McDonald, Allan E. Rettie, Amanda L. Johnson, Shinya Fujii, Hiroyuki Kagechika
Publikováno v:
Journal of Lipid Research, Vol 60, Iss 4, Pp 892-899 (2019)
Vitamin K (VK), in both its phylloquinone and menaquinone forms, has been hypothesized to undergo ω- and β-oxidation on its hydrophobic side chain in order to generate the observed urinary metabolites, K acid I and K acid II, which are excreted pri
Publikováno v:
Xenobiotica; the fate of foreign compounds in biological systems. 51(8)
8-[(1H-1,2,3-benzotriazol-1-yl)amino]octanoic acid (8-BOA) was recently identified as a selective and potent mechanism-based inactivator (MBI) of breast cancer-associated CYP4Z1 and exhibited favourable inhibitory activity
8‐[(1H‐1,2,3‐benzotriazol‐1‐yl)amino]octanoic acid (8-BOA) was recently identified as a selective and potent mechanism-based inactivator (MBI) of breast cancer-associated CYP4Z1 and exhibited favourable inhibitory activity in vitro, thus me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01b53bcc8bf55a84f9624d1c38c8807f